TY - JOUR T1 - Assembly 12: interstitial lung diseases JF - Breathe JO - Breathe SP - 345 LP - 346 DO - 10.1183/20734735.026518 VL - 14 IS - 4 AU - Katerina Antoniou AU - Athina Trachalaki AU - Eleni Bibaki AU - Venerino Poletti Y1 - 2018/12/01 UR - http://breathe.ersjournals.com/content/14/4/345.abstract N2 - Assembly 12 is a dynamic, new ERS assembly that arose following the continuous expansion of Clinical Assembly group 1.5 (diffuse parenchymal lung disease). It focuses on interstitial lung diseases (ILDs) and accommodates the following groups: 12.01) idiopathic interstitial pneumonias; 12.02) ILD/diffuse parenchymal lung diseases (DPLD) of known origin; 12.03) sarcoidosis and other granulomatous ILD/DPLD; and 12.04) rare ILD/DPLD. Following its creation in September 2017, Assembly 12 gathered 4% of all the ERS members affiliated to an assembly. The number of members in Assembly 12 has been steadily increasing, reaching a total of 735 in August 2018. Group 12.01 (idiopathic interstitial pneumonias) is the most popular group. Young respiratory scientists have strong representation in our Assembly, up to 39% of the Assembly members are early career members.Meet @ERStalk Assembly 12: interstitial lung diseases http://ow.ly/Bp0730m9zX4 ER -